As of 2024-12-15, the EV/EBITDA ratio of Avid Bioservices Inc (CDMO) is -18.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDMO's latest enterprise value is 917.95 mil USD. CDMO's TTM EBITDA according to its financial statements is -50.21 mil USD. Dividing these 2 quantities gives us the above CDMO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 16.5x | 14.8x |
| Forward P/E multiples | 18.6x - 26.3x | 22.8x |
| Fair Price | (12.63) - 8.85 | (3.14) |
| Upside | -202.3% - -28.3% | -125.5% |
| Date | EV/EBITDA |
| 2024-12-13 | -18.28 |
| 2024-12-12 | -18.24 |
| 2024-12-11 | -18.14 |
| 2024-12-10 | -18.24 |
| 2024-12-09 | -18.19 |
| 2024-12-06 | -18.21 |
| 2024-12-05 | -18.22 |
| 2024-12-04 | -18.23 |
| 2024-12-03 | -18.26 |
| 2024-12-02 | -18.26 |
| 2024-11-29 | -18.21 |
| 2024-11-27 | -18.29 |
| 2024-11-26 | -18.27 |
| 2024-11-25 | -18.23 |
| 2024-11-22 | -18.23 |
| 2024-11-21 | -18.17 |
| 2024-11-20 | -18.13 |
| 2024-11-19 | -18.09 |
| 2024-11-18 | -18.05 |
| 2024-11-15 | -18.03 |
| 2024-11-14 | -17.76 |
| 2024-11-13 | -18.10 |
| 2024-11-12 | -18.14 |
| 2024-11-11 | -18.17 |
| 2024-11-08 | -18.18 |
| 2024-11-07 | -18.15 |
| 2024-11-06 | -16.55 |
| 2024-11-05 | -15.99 |
| 2024-11-04 | -15.73 |
| 2024-11-01 | -15.65 |
| 2024-10-31 | -15.25 |
| 2024-10-30 | -15.49 |
| 2024-10-29 | -15.53 |
| 2024-10-28 | -15.43 |
| 2024-10-25 | -15.30 |
| 2024-10-24 | -15.57 |
| 2024-10-23 | -15.76 |
| 2024-10-22 | -15.85 |
| 2024-10-21 | -15.35 |
| 2024-10-18 | -15.49 |
| 2024-10-17 | -15.49 |
| 2024-10-16 | -15.56 |
| 2024-10-15 | -15.65 |
| 2024-10-14 | -15.47 |
| 2024-10-11 | -15.71 |
| 2024-10-10 | -15.52 |
| 2024-10-09 | -15.76 |
| 2024-10-08 | -15.75 |
| 2024-10-07 | -15.91 |
| 2024-10-04 | -16.10 |